- Home
- TELO vs TSVT Comparison
TELO vs TSVT Comparison
Compare TELO & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- TSVT
- Stock Information
- Founded
- TELO 2021
- TSVT 2021
- Country
- TELO United States
- TSVT United States
- Employees
- TELO N/A
- TSVT N/A
- Industry
- TELO
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- TELO
- TSVT Health Care
- Exchange
- TELO NYSE
- TSVT Nasdaq
- Market Cap
- TELO 154.1M
- TSVT 128.5M
- IPO Year
- TELO 2024
- TSVT N/A
- Fundamental
- Price
- TELO $3.91
- TSVT $2.61
- Analyst Decision
- TELO
- TSVT Buy
- Analyst Count
- TELO 0
- TSVT 4
- Target Price
- TELO N/A
- TSVT $8.50
- AVG Volume (30 Days)
- TELO 122.3K
- TSVT 278.0K
- Earning Date
- TELO 02-04-2025
- TSVT 03-04-2025
- Dividend Yield
- TELO N/A
- TSVT N/A
- EPS Growth
- TELO N/A
- TSVT N/A
- EPS
- TELO N/A
- TSVT N/A
- Revenue
- TELO N/A
- TSVT $45,620,000.00
- Revenue This Year
- TELO N/A
- TSVT N/A
- Revenue Next Year
- TELO N/A
- TSVT $37.70
- P/E Ratio
- TELO N/A
- TSVT N/A
- Revenue Growth
- TELO N/A
- TSVT N/A
- 52 Week Low
- TELO $3.11
- TSVT $2.29
- 52 Week High
- TELO $9.54
- TSVT $6.00
- Technical
- Relative Strength Index (RSI)
- TELO 40.31
- TSVT 50.02
- Support Level
- TELO $3.75
- TSVT $2.38
- Resistance Level
- TELO $4.83
- TSVT $2.82
- Average True Range (ATR)
- TELO 0.32
- TSVT 0.18
- MACD
- TELO -0.05
- TSVT 0.04
- Stochastic Oscillator
- TELO 13.01
- TSVT 58.18
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.